Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription Articles published in Oncogene Retrieve available abstracts of 43 articles: HTML format

Single Articles

April 2008
1. CHEN R , Alvero AB, Silasi DA, Kelly MG, et al
   Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
2. SASAKI H , Hayakawa J, Terai Y, Kanemura M, et al
   Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
   Oncogene. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. CHEN R , Alvero AB, Silasi DA, Steffensen KD, et al
   Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
   Oncogene. 2008;27:225-33.
   PubMed     Related articles    Abstract available
   
   
   December 2007
4. BAIRD SK , Aerts JL, Eddaoudi A, Lockley M, et al
   Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   October 2007
5. GLAROS S , Cirrincione GM, Muchardt C, Kleer CG, et al
   The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
   Oncogene. 2007;26:7058-66.
   PubMed     Related articles    Abstract available
   
   
   
6. TORNG PL , Lee YC, Huang CY, Ye JH, et al
   Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   September 2007
7. COOPER WN , Dickinson RE, Dallol A, Grigorieva EV, et al
   Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
8. JENG YM , Cai-Ng S, Li A, Furuta S, et al
   Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
   Oncogene. 2007;26:6160-6.
   PubMed     Related articles    Abstract available
   
   
   
9. ZISMAN-ROZEN S , Fink D, Ben-Izhak O, Fuchs Y, et al
   Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
   Oncogene. 2007;26:6093-8.
   PubMed     Related articles    Abstract available
   
   
   
10. YULI C , Shao N, Rao R, Aysola P, et al
    BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
    Oncogene. 2007;26:6031-7.
    PubMed     Related articles    Abstract available
    
    
    August 2007
11. GRIFONI D , Garoia F, Bellosta P, Parisi F, et al
    aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.
    Oncogene. 2007;26:5960-5.
    PubMed     Related articles    Abstract available
    
    
    
12. MAHANIVONG C , Chen HM, Yee SW, Pan ZK, et al
    Protein kinase Calpha-CARMA3 signaling axis links Ras to NF-kappaB for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
13. HE X , Pool M, Darcy KM, Lim SB, et al
    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
    Oncogene. 2007;26:4961-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
14. GOTO T , Takano M, Albergaria A, Briese J, et al
    Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. KOBEL M , Weidensdorfer D, Reinke C, Lederer M, et al
    Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
16. POLLOCK PM , Gartside MG, Dejeza LC, Powell MA, et al
    Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. SENGUPTA S , Kim KS, Berk MP, Oates R, et al
    Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Oncogene. 2007;26:2894-901.
    PubMed     Related articles    Abstract available
    
    
    February 2007
18. STAUB J , Chien J, Pan Y, Qian X, et al
    Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
19. VIDAL GA , Clark DE, Marrero L, Jones FE, et al
    A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
    Oncogene. 2007;26:462-6.
    PubMed     Related articles    Abstract available
    
    
    
20. YAO JJ , Liu Y, Lacorazza HD, Soslow RA, et al
    Tumor promoting properties of the ETS protein MEF in ovarian cancer.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. APPIERTO V , Villani MG, Cavadini E, Gariboldi M, et al
    Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Oncogene. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
22. NANJUNDAN M , Zhang F, Schmandt R, Smith-McCune K, et al
    Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
23. BASAKI Y , Hosoi F, Oda Y, Fotovati A, et al
    Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
24. LI J , Wood WH 3rd, Becker KG, Weeraratna AT, et al
    Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
25. MULHERKAR N , Ramaswamy M, Mordi DC, Prabhakar BS, et al
    MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
    Oncogene. 2006;25:6252-61.
    PubMed     Related articles    Abstract available
    
    
    
26. BERLINGIERI MT , Pallante P, Guida M, Nappi C, et al
    UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
27. DIFEO A , Narla G, Camacho-Vanegas O, Nishio H, et al
    E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    Oncogene. 2006;25:6026-31.
    PubMed     Related articles    Abstract available
    
    
    
28. DOMCHEK SM , Weber BL
    Clinical management of BRCA1 and BRCA2 mutation carriers.
    Oncogene. 2006;25:5825-31.
    PubMed     Related articles    Abstract available
    
    
    
29. YANG G , Rosen DG, Colacino JA, Mercado-Uribe I, et al
    Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
30. SOPRANO KJ , Purev E, Vuocolo S, Soprano DR, et al
    Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid.
    Oncogene. 2006;25:5315-25.
    PubMed     Related articles    Abstract available
    
    
    
31. SCAMBIA G , Lovergine S, Masciullo V
    RB family members as predictive and prognostic factors in human cancer.
    Oncogene. 2006;25:5302-8.
    PubMed     Related articles    Abstract available
    
    
    
32. CODY NA , Ouellet V, Manderson EN, Quinn MC, et al
    Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    July 2006
33. BIGNONE PA , Lee KY, Liu Y, Emilion G, et al
    RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
34. LEONG CT , Ong CK, Tay SK, Huynh H, et al
    Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
35. MOTAMED-KHORASANI A , Jurisica I, Letarte M, Shaw PA, et al
    Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    May 2006
36. WANI AA , Sharma N, Shouche YS, Bapat SA, et al
    Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
37. CASLINI C , Capo-Chichi CD, Roland IH, Nicolas E, et al
    Histone modifications silence the GATA transcription factor genes in ovarian cancer.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
38. PENG M , Litman R, Jin Z, Fong G, et al
    BACH1 is a DNA repair protein supporting BRCA1 damage response.
    Oncogene. 2006;25:2245-53.
    PubMed     Related articles    Abstract available
    
    
    
39. BIAN D , Mahanivong C, Yu J, Frisch SM, et al
    The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
    Oncogene. 2006;25:2234-44.
    PubMed     Related articles    Abstract available
    
    
    March 2006
40. WANG TH , Chan YH, Chen CW, Kung WH, et al
    Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
41. EHRLICH M , Woods CB, Yu MC, Dubeau L, et al
    Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    February 2006
42. LI H , Zhang Y, Su T, Santella RM, et al
    Hint1 is a haplo-insufficient tumor suppressor in mice.
    Oncogene. 2006;25:713-21.
    PubMed     Related articles    Abstract available
    
    
    August 2005
43. SYED V , Zhang X, Lau KM, Cheng R, et al
    Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Oncogene 2005;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: